Literature DB >> 17877616

Human ovarian surface epithelial cells immortalized with hTERT maintain functional pRb and p53 expression.

N F Li1, S Broad, Y J Lu, J S Yang, R Watson, T Hagemann, G Wilbanks, I Jacobs, F Balkwill, D Dafou, S A Gayther.   

Abstract

OBJECTIVE: Cell immortalization is considered to be a prerequisite status for carcinogenesis. Normal human ovarian surface epithelial (OSE) cells, which are thought to be the origin of most of human ovarian carcinomas, have a very limited lifespan in culture. Establishment of immortalized OSE cell lines has, in the past, required inactivation of pRb and p53 functions. However, this often leads to increased chromosome instability during prolonged culture.
MATERIALS AND METHODS: In this study, we have used a retroviral infection method to overexpress human telomerase reverse transcriptase (hTERT) gene, in primary normal OSE cells, under optimized culture conditions.
RESULTS: In vitro and in vivo analysis of hTERT-immortalized cell lines confirmed their normal epithelial characteristics. Gene expression profiles and functional analysis of p16(INK4A), p15(INK4B), pRb and p53 confirmed the presence of their intact functions. Our study suggests that inactivation of pRb and p53 is not necessary for OSE immortalization. Furthermore, down-regulation of p15(INK4B) in the immortalized cells may indicate a functional role for this protein in them.
CONCLUSION: These immortal OSE cell lines are likely to be an important tool for studying human OSE biology and carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17877616      PMCID: PMC6495942          DOI: 10.1111/j.1365-2184.2007.00462.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  46 in total

Review 1.  Normal ovarian surface epithelium.

Authors:  Alice S T Wong; Nelly Auersperg
Journal:  Cancer Treat Res       Date:  2002

2.  Effects of double-strand break repair proteins on vertebrate telomere structure.

Authors:  Chao Wei; Rose Skopp; Minoru Takata; Shunichi Takeda; Carolyn M Price
Journal:  Nucleic Acids Res       Date:  2002-07-01       Impact factor: 16.971

3.  Telomerase catalytic subunit homologs from fission yeast and human.

Authors:  T M Nakamura; G B Morin; K B Chapman; S L Weinrich; W H Andrews; J Lingner; C B Harley; T R Cech
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

4.  Expression of FHIT in primary cultures of human epithelial ovarian tumors and malignant ovarian ascites.

Authors:  A P Manning; A M Mes-Masson; R J Seymour; M Tetrault; D M Provencher; P N Tonin
Journal:  Mol Carcinog       Date:  1999-03       Impact factor: 4.784

5.  Spontaneous malignant transformation of human ovarian surface epithelial cells in vitro.

Authors:  L Gregoire; R Rabah; E M Schmelz; A Munkarah; P C Roberts; W D Lancaster
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

6.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

7.  A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer.

Authors:  Huchun Li; Tae-Hee Lee; Hava Avraham
Journal:  J Biol Chem       Date:  2002-03-26       Impact factor: 5.157

8.  Control of replicative life span in human cells: barriers to clonal expansion intermediate between M1 senescence and M2 crisis.

Authors:  J A Bond; M F Haughton; J M Rowson; P J Smith; V Gire; D Wynford-Thomas; F S Wyllie
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

9.  Phyllodes tumors of the breast analyzed by comparative genomic hybridization and association of increased 1q copy number with stromal overgrowth and recurrence.

Authors:  Y J Lu; S Birdsall; P Osin; B Gusterson; J Shipley
Journal:  Genes Chromosomes Cancer       Date:  1997-11       Impact factor: 5.006

10.  Establishment of an immortalised human ovarian surface epithelial cell line without chromosomal instability.

Authors:  T Maeda; H Tashiro; H Katabuchi; M Begum; H Ohtake; T Kiyono; H Okamura
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

View more
  14 in total

1.  Oncolytic virotherapy for ovarian cancer.

Authors:  Shoudong Li; Jessica Tong; Masmudur M Rahman; Trevor G Shepherd; Grant McFadden
Journal:  Oncolytic Virother       Date:  2012-08

2.  Senescent fibroblasts promote neoplastic transformation of partially transformed ovarian epithelial cells in a three-dimensional model of early stage ovarian cancer.

Authors:  Kate Lawrenson; Barbara Grun; Elizabeth Benjamin; Ian J Jacobs; Dimitra Dafou; Simon A Gayther
Journal:  Neoplasia       Date:  2010-04       Impact factor: 5.715

3.  Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers.

Authors:  Dimitra Dafou; Barbara Grun; John Sinclair; Kate Lawrenson; Elizabeth C Benjamin; Estrid Hogdall; Susanne Kruger-Kjaer; Lise Christensen; Heidi M Sowter; Ahmed Al-Attar; Richard Edmondson; Stephen Darby; Andrew Berchuck; Peter W Laird; C Leigh Pearce; Susan J Ramus; Ian J Jacobs; Simon A Gayther
Journal:  Neoplasia       Date:  2010-07       Impact factor: 5.715

4.  Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer.

Authors:  Alan G Ramsay; Andrew J Clear; Rewas Fatah; John G Gribben
Journal:  Blood       Date:  2012-04-30       Impact factor: 22.113

5.  Organotypic culture model of pancreatic cancer demonstrates that stromal cells modulate E-cadherin, beta-catenin, and Ezrin expression in tumor cells.

Authors:  Fieke E M Froeling; Tariq A Mirza; Roger M Feakins; Angela Seedhar; George Elia; Ian R Hart; Hemant M Kocher
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

6.  p21 Promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker.

Authors:  Magdalena B Flak; Claire M Connell; Claude Chelala; Kyra Archibald; Michael A Salako; Katrina J Pirlo; Michelle Lockley; Sally P Wheatley; Frances R Balkwill; Iain A McNeish
Journal:  Mol Cancer       Date:  2010-07-03       Impact factor: 27.401

7.  Inflammatory cytokine tumor necrosis factor alpha confers precancerous phenotype in an organoid model of normal human ovarian surface epithelial cells.

Authors:  Joseph Kwong; Franky Leung Chan; Kwong-kwok Wong; Michael J Birrer; Kyra M Archibald; Frances R Balkwill; Ross S Berkowitz; Samuel C Mok
Journal:  Neoplasia       Date:  2009-06       Impact factor: 5.715

8.  Sequential genetic change at the TP53 and chemokine receptor CXCR4 locus during transformation of human ovarian surface epithelium.

Authors:  K M Archibald; H Kulbe; J Kwong; P Chakravarty; J Temple; T Chaplin; M B Flak; I A McNeish; S Deen; J D Brenton; B D Young; F Balkwill
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

9.  Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms.

Authors:  Paul Michael Jones; Ronny Drapkin
Journal:  Front Oncol       Date:  2013-08-26       Impact factor: 6.244

10.  Vaccinia virus induces programmed necrosis in ovarian cancer cells.

Authors:  Lynsey M Whilding; Kyra M Archibald; Hagen Kulbe; Frances R Balkwill; Daniel Öberg; Iain A McNeish
Journal:  Mol Ther       Date:  2013-09-24       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.